Globally approximately 85% of the research applications submitted to government funding agencies go unfunded. This leaves an innovation gap that may stifle research discovery and delay discoveries that could advance potential treatments and cures for many diseases.
OnPAR seeks to provide a funding alternative to the research community’s restraints imposed by limitations in government funding. OnPAR members include private foundations, pharmaceuticals and other private funders that will review research ideas submitted for consideration. The more research ideas OnPAR gets, the more funders will join to potentially partner and fund research projects, and the closer we will be to treatments and the potential cures for our communities.
The goal of OnPAR is to fund highly scored unfunded applications from NIH, NSF, FDA, CDC, DOE, NASA and other funding agencies –national and international. Internationally, the EU Commission, E-rare (conglomerate of 26 EU government funding agencies), UK MRC and Innovate UK, Canada CIHR, Aus NHMRC, Japan AMED, NASA, the Department of Energy will start joining in the Fall. Some have already confirmed. For a one page summary on OnPAR, click here.